A non-randomized, open-label study of the safety and effectiveness
4.7 (481) · $ 16.00 · In stock
Equillium - Final Safety and Efficacy Results from EQUATE, an Open
Articles in 2022 Scientific Reports
PDF) Superior Clinical, Quality of Life, Functional, and Health Economic Outcomes with Pneumatic Compression Therapy for Lymphedema
Atezolizumab in combination with carboplatin plus nab-paclitaxel
Controlled and Uncontrolled Clinical Trials
PDF) Assessment of quality of life changes in patients with lower extremity lymphedema using an advanced pneumatic compression device at home
A Meta-analysis of Randomized Controlled Trials Comparing the
How to Search for Clinical Studies
Study design: the randomized controlled crossover trial. Each
PDF) Safety and Efficacy of Nanosecond Pulsed Electric Field
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid
PDF) Author Correction: A non-randomized, open-label study of the safety and effectiveness of a novel non-pneumatic compression device (NPCD) for lower limb lymphedema
Lymphedema techniques to manage edema after SCI: a retrospective analysis
Stanley ROCKSON, Allan and Tina Neill Professor of Lymphatic Research and Medicine/Chief of Consultative Cardiology, Stanford University, CA, SU, Division of Cardiovascular Medicine
